These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35054002)

  • 21. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China.
    Qu J; Chen S; Bao F; Gu L; Cao B
    Int J Infect Dis; 2019 Jun; 83():26-31. PubMed ID: 30926541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.
    Okada T; Morozumi M; Tajima T; Hasegawa M; Sakata H; Ohnari S; Chiba N; Iwata S; Ubukata K
    Clin Infect Dis; 2012 Dec; 55(12):1642-9. PubMed ID: 22972867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018.
    Zhao S; Musa SS; Qin J; He D
    Int J Infect Dis; 2019 Apr; 81():251-253. PubMed ID: 30822543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials.
    Kim HS; Sol IS; Li D; Choi M; Choi YJ; Lee KS; Seo JH; Lee YJ; Yang HJ; Kim HH
    BMC Pulm Med; 2019 Dec; 19(1):251. PubMed ID: 31852460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.
    Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Kim Y; Kim S; Park C; Seo JH; Sol IS; Sung M; Song MS; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung EH; Chung HL; Choi SM; Choi YJ; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ;
    BMC Infect Dis; 2020 Feb; 20(1):132. PubMed ID: 32050912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.
    Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH
    BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current perspectives on atypical pneumonia in children.
    Shim JY
    Clin Exp Pediatr; 2020 Dec; 63(12):469-476. PubMed ID: 32517424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of Macrolide-Resistant
    Hubert D; Dumke R; Weichert S; Welker S; Tenenbaum T; Schroten H
    Pathogens; 2021 Mar; 10(3):. PubMed ID: 33802078
    [No Abstract]   [Full Text] [Related]  

  • 29. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
    Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
    J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional and annual patterns in respiratory virus co-infection etiologies and antibiotic prescriptions for pediatric mycoplasma pneumoniae pneumonia.
    Sung M; Choi HJ; Lee MH; Lee JY; Kim HB; Ahn YM; Kim JK; Kim HY; Jung SS; Kim M; Kang EK; Yang EA; Lee SJ; Park Y; Seo JH; Lee E; Yang ES; Park KS; Shin M; Chung HL; Jang YY; Choi BS; Kim H; Jung JA; Yu ST; Roh EJ; Lee ES; Kim JT; Kim BS; Hwang YH; Sol IS; Yang HJ; Han MY; Yew HY; Cho HM; Kim HY; Hn YH; Im DH; Hwang K; Yoo J; Jung SO; Jeon YH; Shim JY; Chung EH
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5844-5856. PubMed ID: 36066160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrolide-resistant Mycoplasma pneumoniae pneumonia in transplantation: Increasingly typical?
    Eschenauer GA; Xiao L; Waites KB; Crabb DM; Ratliff AE; Gandhi TN; Riddell J; Kaul DR
    Transpl Infect Dis; 2020 Oct; 22(5):e13318. PubMed ID: 32386104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
    Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of resistance acquisition and treatment of macrolide-resistant
    Yang HJ; Song DJ; Shim JY
    Korean J Pediatr; 2017 Jun; 60(6):167-174. PubMed ID: 28690643
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent Trend of Antimicrobial Susceptibility among
    Oishi T; Yoshioka D; Nakano T; Ouchi K
    Microorganisms; 2022 Dec; 10(12):. PubMed ID: 36557681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycoplasma pneumoniae in pediatric patients: Do macrolide-resistance and/or delayed treatment matter?
    Yang TI; Chang TH; Lu CY; Chen JM; Lee PI; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2019 Apr; 52(2):329-335. PubMed ID: 30341022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First Detection and Characterization of Macrolide-Resistant
    Noori Goodarzi N; Pourmand MR; Arfaatabar M; Azimi G; Masoorian E; Rahimi Foroushani A; Aminharati F; Heidarzadeh S; Baghani A
    Microb Drug Resist; 2020 Mar; 26(3):245-250. PubMed ID: 31545147
    [No Abstract]   [Full Text] [Related]  

  • 37. Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental
    Bae E; Kim YJ; Kang HM; Jeong DC; Kang JH
    Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36140012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis.
    Kim K; Jung S; Kim M; Park S; Yang HJ; Lee E
    JAMA Netw Open; 2022 Jul; 5(7):e2220949. PubMed ID: 35816304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children.
    Yang HJ
    Korean J Pediatr; 2019 Jun; 62(6):199-205. PubMed ID: 30999732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in adults.
    Hanada S; Morozumi M; Takahashi Y; Mochizuki S; Sato T; Suzuki S; Uruga H; Takaya H; Miyamoto A; Morokawa N; Ubukata K; Kishi K
    Intern Med; 2014; 53(15):1675-8. PubMed ID: 25088885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.